Medizinalpilze komplementär bei gynäkologischen Tumoren

Zusammenfassung

Während die westliche Medizin beim therapeutischen Einsatz von Pilzen an die Wirkstoffe niederer Pilze denkt, wie das Penicillin, stehen die Fruchtkörper höherer Großpilze in der asiatischen Medizin schon seit Jahrtausenden an der Spitze der eingesetzten Arzneidrogen. Internationale Kongresse befassen sich seit den 1970er-Jahren mit deren Heilwirkung und positive Forschungsergebnisse brachten die Pilze bis ins offizielle Therapieschema asiatischer Krebstherapien. Ein aktuelles Review zum Einsatz medizinisch wirksamer Pilze beim Mammakarzinom zeigt erneut Tendenzen unterstützender Wirkungen. Daher sollen die weltweit am häufigsten verwendeten Medizinalpilze und deren komplementäre Einsatzmöglichkeiten vorgestellt werden.

Summary

Medical fungi have a very long tradition in the herbal medicine of Asian countries like China and Japan. In the 1970ths research started in western medicine. Medical mushrooms show promising results in adjuvant cancer treatment, especially by improving immunological und hematologic parameters as well as quality of life. In 2011, a review concerning breast cancer again reports positive effects, even if further clinical studies are needed to elucidate the mechanism of action and the medical benefits. The paper gives an overview about the most common medical mushrooms applied in gynecological tumors and informs about the possible indications, side-effects, contraindications and benefits.

Schlüsselwörter

Medizinalpilze - Vitalpilze - Mammakarzinom - Ovarialkarzinom - Immunmodulation - Lebensqualität - Komplementäronkologie - Shiitake - Reishi - Maitake - ABM - Cordyceps - Polyporus - Coriolus

Keywords

Medical mushrooms - breast cancer - ovarian cancer - immune modulation - quality of life - complementary oncology - Shiitake - Reishi - Maitake - ABM - Cordyceps - Polyporus - Coriolus

• Literatur

• 1 Ahn WS et al Natural killer cell activity and quality of life were improved by consumption of a mushroom extract. Int J Gynecol Cancer 2004; 14(4): 589-94
• 2 AltMedDex® Evaluations Maitake Micromedex^® Healthcare Series (Thomson Micromedex) 2007a.1−14
• 3 Bianchi I. Moderne Mykotherapie. Niederdorffelden: alpha-One AG; 2009
• 4 Bihlmaier S. Tomatenrot + Drachengrün, Antikrebsaktiv und abwehrstark. 3. Aufl. Weil der Stadt: Hädecke; 2014
• 5 Bucci LR. Selected herbals and human exercise performance. Am J Clin Nutr 2000; 72(2Part2): 624-36
• 6 Büssing A, Hübner J. Asiatische Heilpilze. Der Onkologe 2009; 15: 519-25
• 7 Chen S et al Chemopreventive properties of mushrooms against breast cancer and prostate cancer. Int J Medicinal Mushrooms 2005; 7: 342-43
• 8 Dolby V. An extract from maitake mushroom is an important anticancer agent. Better Nutr 1997; 59: 38-59
• 9 Fisher M, Yang LX. Anticancer effects and mechanisms of polysaccharide-K: Implications of cancer immunotherapy. Anticancer Res 2002; 22: 1737-54
• 10 Gao Y, Dai X, Chen G, Ye J et al A randomized, placebo-controlled, multicenter study of Ganoderma lucidum polysaccharides in patients with advanced lung cancer. Int J Med Mushrooms 2003; 5: 369-81
• 11 Gonzalez CA, Riboli E. Diet and cancer prevention: contributions from the EPIC study. Eur J Cancer 2010; 46(14): 2555-62
• 12 Haug Report Medizinalpilze in der ganzheitlichen Krebstherapie. Sonderdruck 2014
• 13 Herr I. Ernährung, Nahrungsergänzung und Krebs. GfbK-Kongress Vortrag 4.5.2013
• 14 Holliday J, Cleaver M. On the Trail of the Yak, Ancient Cordyceps in the Modern World. Intern. Presentation. In: Lelley JI. Die Heilkraft der Pilze. Goch B. o. s.s Druck und Medien GmbH; 2004
• 15 Hong SA et al A case-control study on the dietary intake of mushrooms and breast cancer risk among Korean women. Int J Cancer 2008; 122: 919-23
• 16 Hsu CC et al In vivo and in vitro stimulatory effects of Cordyceps sinensis on testosterone production in mouse Leydig cells. Life Sci 2003; Sept 5 73(16): 2127-36
• 17 IIino Y et al Immunochemotherapy versus chemotherapy as adjuvant treatment after curative resection of operable breast cancer. Anticancer Res 1995; 15: 2907-12
• 18 Jacob L. Dr. Jacobs Weg des genussvollen Verzichts. nutricaMEDia;
• 19 Jiang J, Slivova V, Silva D. Ganoderma Lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappa signaling. Int J Oncol 2006; 29: 695-703
• 20 Ju YH, Fultz J, Allred KF et al Effects of dietary daidzein and its metabolite, equol, at physiological concentrations on the growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in ovariectomized athymic mice. Carcinogenesis 2006; 27: 856-63
• 21 Keinan-Broker L et al Dietary phytoestrogens and breast cancer risk. Am J Clin Nutr 2004; 79: 282-88
• 22 Kodama N, Komuta K, Nanab H. Can maitake MD-fraction aid cancer patients?. Altern Med Rev 2002; 7: 236-9
• 23 Lelley JI. Die Heilkraft der Pilze. 4. Aufl. Goch B. o. s.s Druck und Medien GmbH; 2008
• 24 Levis S et al Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms. Arch Intern Med 2011; 171(15): 1363-9
• 25 Lindequist U, Rausch R, Füssel A, Hanssen P. Höhere Pilze in der traditionellen Heilkunde und Medizin. MMP 2010; 33(2): 40-8
• 26 Li Shi-Zhen (16 Jahrhundert) Pen ts’ao kang mu. (Originaltitel mit alter Schreibweise, Chinese Herbal and Materia Medica)
• 27 Lin ZB, Zhang HN. Anti-tumor and immunoregulatory activities of Ganoderma lucidum and its possible mechanisms. Acta Pharmacol Sin 2004; 25: 1387-95
• 28 Lull C et al Antiinflammatory and immunomodulating properties of fungal metabolites. Mediators Inflamm 2005; 2: 63-80
• 29 Maruyama S, Sukekawa Y, Kaneko Y, Fujimot S. Antitumor activities of lentinan and micellapist in tumor-bearing mice. Gan To Kagaku Ryoho 2006; 33: 1726-9
• 30 Masuda Y, Inoue M, Miyata A, Mizuno S et al Maitake beta-glucan enhances therapeutic effects and reduces myelosupression and neprotoxicitiy of cisplatin in mice. Int Immunopharmacol 2009; 9: 620-6
• 31 Mukai H et al An Alternative Medicine, Agaricus blazei, May Have Induced Severe Hepatic Dysfunction in Cancer Patients. Jpn J Clin Oncol 2006; 36(12): 808-10
• 32 Nakano H, Namatame K, Nemoto H et al A multi-institutional prospective study of lentinan in advanced gastric cancer patients with unresectable and recurrent diseases: Effect on prolongation of survival and improvement of quality of life. Kanagawa Lentinan Research Group. Hepatogastroenterol 1999; 46: 2662-8
• 33 Ng TB. A review of research on the protein-bound polysaccharide (polysaccharopeptide PSP) from the mushroom Coriolus versicolor (Basidiomycetes Polyporaceae). Gen Pharmacol 1998; 30(1): 1-4
• 34 Novaes M, Valadares F, Reis MC, Goncalves DR, Menezes MC. The effect of dietary supplementation with Agarical mushrooms and other medicinal fungi on breast cancer: evidence-based medicine.. Clinics (Sao Paulo) 2011; 66 (12): 2133-9
• 35 Oba K, Kobayashi M, Matsui T, Kodera Y et al Individual patient based meta-analysis of lentinan for unresectable/recurrent gastric cancer. Anticancer Res 2009; 7: 2739-45
• 36 Ochiai T, Isono K, Suzuki T, Koide Y et al Effect of immunotherapy with lentinan on patients survival and immunological parameters in patients with advanced gastric cancer − results of a multicenter randomized controlled study. Int J Immunother 1992; 8: 161-9
• 37 Poisindex^® Product List. Ganoderma lucidum. Micromedex^® Healthcare Series 2007
• 38 Rauch-Petz. Sojaprodukte in Wechseljahren gut, bei Brustkrebs schlecht?. Interview inkl. Quellen auf www.netzwerk-frauengesundheit.com
• 39 Saif A, Lindequist U, Wende C. Stimmulating effects of Grifola frondosa (Maitake) on human osteoblastic cell cultures. J Nat Med 2007; 61: 231-8
• 40 Satoshi O et al Phase I Clinical Study of the Dietary Supplement Agaricus blazei murill in Cancer Patients in Remission. Evid Based Complement Alternat Med 2011; http://dx.doi.org/10.1155/2011/192381
• 41 Schultes RE, Hofmann A. Pflanzen der Götter. Die magischen Kräfte der Rausch- und Giftgewächse. Aarau/Schweiz: AT-Verlag; 1996
• 42 See D, Mason S, Rsohan R. Increased tumor necrosis factor alpha and natural killer cells function using an integrative approach an late stage cancers. Immunol Invest 2002; 31: 137-53
• 43 Shin A et al Dietary mushroom intake and risk of breast cancer based on hormone receptor states. Nutr Cancer 2010; 62: 476-83
• 44 Toi M et al Randomized adjuvant trial to evaluate the addition of tamoxifen and PSK to chemotherapy in patients with primary breast cancer. 5-years results from the Nishi-Nippon Group of the Adjuvant Chemoendocrine Therapy for Breast Cancer Organisation. Cancer 1992; 70(10): 2475-83
• 45 UGB Forum Spezial. Aktiv gegen Krebs. Sonderheft der Unabhängigen Gesundheitsberatung 2011;
• 46 University of Texas, MD Anderson Cancer Center. Coriolus versicolor: Detailed scientific review. Accessed at: www.mdanderson.org/departments/CIMER/display.cfm?id=BF40CDD9-ED6B-11D4−810200508B603A14&method=displayFull&pn=6EB86A59-EBD9−11D4−810100508B603A14 on June 10, 2008
• 47 Yokoe T et al HLA antigens predictive index for the outcome of breast cancer patients with adjuvant immunochemotherapy with PSK. Anticancer Res 1997; 17(4A): 2815-8
• 48 Yuan D, Mori J, Komatsu KI, Makino T, Jano Y. An anti-aldosteronic diuretic component in Polyporus slerotium. Biol Pharm Bull 2004; 27(6): 867-70
• 49 Wasser SP, Weis AL. Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: a modern perspective. Crit Rev Immunol 1999; 19(1): 65-96
• 50 Wong CK et al Immunomodulatory activities of Yunzhi and Danshen in post-treatment breast cancer patients. Am J Chin Med 2005; 33(3): 381-95
• 51 World Cancer Research Fund, American Institute for Cancer Research. Weltkrebsbericht. London 2007 www.dietandcancerreport.org